[1]
“Tuberculosis and Human Immunodeficiency Virus Co-Infection: Clinico-Demographic Determinants at an Anti-Retroviral Therapy Center in Northern India”, SAARC J. Tuber. Lung Dis. HIV/AIDS, vol. 14, no. 2, pp. 12–17, Mar. 2018, doi: 10.3126/saarctb.v14i2.19333.